Emerging drugs for head and neck cancer

Author： Rhee John C   Khuri Fadlo R   Shin Dong M  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.9, Iss.1, 2004-05, pp. : 91-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging tyrosine kinase inhibitors for head and neck cancer

By Bossi Paolo   Locati Laura   Licitra Lisa  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 4, 2013-12 ,pp. : 445-459

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs to treat squamous cell carcinomas of the head and neck

By Fung Christopher   Grandis Jennifer R  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. : 355-373

Informa Healthcare

Access to resources Recommend Favorite

Emerging molecular targeted therapies in the treatment of head and neck cancer

By Bozec Alexandre   Peyrade Frédéric   Fischel Jean-Louis   Milano Gérard  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 299-310

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy in head and neck cancer

By  

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Emerging drugs for colorectal cancer

By Fogelman David R   Kopetz Scott   Eng Cathy  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. : 629-642

Informa Healthcare

Access to resources Recommend Favorite